Targeting TGF-β1 and AKT signal on growth and metastasis of anaplastic thyroid cancer cell in vivo
OBJECTIVE: We have recently reported that therapies targeting TGF-β1 signaling were effective to prevent the anaplastic thyroid cancer (ATC) cell growth, but not the invasion. Phosphatidylinositol 3-kinase (PI3K)/AKT signaling are activated in ATC and play a major role in ATC invasion. Herein, we examined the effects of targeting TGF-β1 by shRNA in combination with pan-AKT inhibitor, MK-2206 … Continue reading Targeting TGF-β1 and AKT signal on growth and metastasis of anaplastic thyroid cancer cell in vivo
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed